The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Bank of America and Oddo BHF cut Whitbread

Wed, 18th Jan 2023 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

----------

FTSE 100

----------

Bank of America cuts Whitbread to 'underperform' (buy) - price target 3,100 (3,300) pence

----------

Deutsche Bank raises Whitbread target to 3,530 (3,100) pence - 'buy'

----------

Oddo BHF cuts Whitbread to 'neutral' (outperform)

----------

Bank of America raises InterContinental Hotels to 'buy' (neutral) - price target 6,300 (5,500) pence

----------

Deutsche Bank raises InterContinental Hotels price target to 5,730 (5,520) pence - 'buy'

----------

Bank of America raises Compass price target to 2,050 (2,000) pence - 'neutral'

----------

Deutsche Bank raises Compass target to 2,000 (1,990) pence - 'hold'

----------

Redburn cuts Shell to 'neutral'

----------

Redburn cuts BP to 'neutral'

----------

Deutsche Bank raises Entain price target to 1,892 (1,800) pence - 'buy'

----------

Deutsche Bank raises Flutter Entertainment price target to 16,116 (15,147) pence - 'buy'

----------

Bank of America cuts Segro to 'neutral' (buy) - price target 840 (850) pence

----------

Bank of America raises Land Securities to 'buy' (neutral) - price target 740 (640) pence

----------

Bank of America raises British Land to 'buy' (underperform) - price target 470 (400) pence

----------

Bernstein raises Tesco price target to 280 (270) pence - 'outperform'

----------

Bernstein raises Sainsbury price target to 210 (200) pence - 'market-perform'

----------

Barclays raises United Utilities target to 1,310 (1,250) pence - 'overweight'

----------

Barclays raises SSE price target to 2,110 (1,835) pence - 'overweight'

----------

Barclays raises Centrica price target to 160 (150) pence - 'overweight'

----------

Berenberg raises AstraZeneca price target to 12,600 (11,800) pence - 'buy'

----------

RBC raises HSBC price target to 750 (725) pence - 'outperform'

----------

Goldman Sachs cuts Beazley price target to 810 (840) pence - 'buy'

----------

Bank of America raises Rio Tinto price target to 7,400 (6,900) pence - 'buy'

----------

Credit Suisse raises NatWest price target to 390 (370) pence - 'outperform'

----------

Credit Suisse cuts Standard Chartered target to 525 (535) pence - 'underperform'

----------

JPMorgan raises Prudential price target to 1,750 (1,500) pence - 'overweight'

----------

Jefferies raises Unilever price target to 4,850 (4,500) pence - 'buy'

----------

FTSE 250

----------

JPMorgan cuts TI Fluid Systems price target to 150 (170) pence - 'overweight'

----------

Kepler Cheuvreux cuts John Wood to 'hold' (buy) - price target 140 (275) pence

----------

Barclays raises John Wood price target to 190 (180) pence - 'equal weight'

----------

Bank of America raises SSP price target to 310 (290) pence - 'buy'

----------

Deutsche Bank research cuts SSP price target to 240 (250) pence - 'hold'

----------

Bank of America raises Carnival price target to 900 (770) pence - 'neutral'

----------

Bank of America cuts Hammerson price target to 18 (20) pence - 'underperform'

----------

Bank of America cuts Workspace price target to 440 (450) pence - 'underperform'

----------

Bank of America raises Capital & Counties to 'neutral' (underperform) - price target 115 (140) pence

----------

Deutsche Bank raises Playtech price target to 608 (601) pence - 'buy'

----------

Deutsche Bank raises Britvic price target to 750 (740) pence - 'hold'

----------

Deutsche Bank raises JD Wetherspoon target to 640 (630) pence - 'buy'

----------

Deutsche Bank raises Tui price target to 1.80 (1.70) EUR - 'hold'

----------

Deutsche Bank raises Tui price target to 152 (140) pence - 'hold'

----------

Deutsche Bank raises Mitchells & Butlers target to 240 (213) pence - 'buy'

----------

Deutsche Bank raises Greggs to 'buy' (hold) - price target 2,950 (1,950) pence

----------

Bank of America raises Great Portland price target to 600 (540) pence - 'neutral'

----------

Bank of America cuts Big Yellow price target to 1400 (1900) pence - 'buy'

----------

Bank of America raises Safestore to 'buy' (neutral) - price target 1200 (1410) pence

----------

Bank of America cuts Derwent London price target to 3,000 (3,100) pence - 'buy'

----------

Goldman Sachs raises Lancashire price target to 655 (635) pence - 'neutral'

----------

Goldman Sachs cuts Hiscox price target to 1325 (1375) pence - 'buy'

----------

SMALL CAP

----------

Kepler Cheuvreux cuts Petrofac to 'reduce' (hold) - price target 70 (140) pence

----------

Berenberg raises Kenmare Resources price target to 780 (710) pence - 'buy'

----------

Deutsche Bank cuts Restaurant Group target to 42 (47) pence - 'hold'

----------

Deutsche Bank raises Marston's target to 50 (44.40) pence - 'hold'

----------

Barclays raises Hunting price target to 420 (390) pence - 'overweight'

----------

Credit Suisse cuts Wise price target to 480 (500) pence - 'neutral'

----------

JPMorgan cuts THG price target to 47 (54) pence - 'underweight'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.